Through a statement, the director of Promotion and Prevention of the Ministry of Health and Social Protection, Gerson Bermont, presented this Friday an x-ray of the progress and challenges of the National Vaccination Plan once morest covid-19.
In this sense, in the Unified Command Post (PMU) 116 from La Dorada, Caldas, which had more than 860 participants, indicated that the country advances by 77.7% in first and only doses; 59.5% in second and single doses, and 16% in booster doses.
“The goal we set for ourselves is to reach a minimum of 80% of the first by January 30,” Bermont said, adding that “this weekend we will be very close to 60% of the population” with complete schemes. “We cannot relax. Ómicron is a very fast variant and the answer we have is to be faster in the Vaccination Plan, to return to our application history”, the official highlighted.
He also presented some data by populations. For example, he highlighted that 189,722 first doses have been applied in pregnant women, 499,508 in migrants, 3,545,866 first doses in children from three to 11 years old, 1,562,225 second doses in children from three to 11 years old and 4,849,402 booster doses in all ages.
© Provided by Week
Colombia received 163,200 doses of vaccines from the AstraZeneca laboratory through the bilateral agreement with this pharmaceutical company.
“In December we had two deaths of unvaccinated pregnant women. The message must be fundamental in this sense”, assured Bermont, making a new call to this population group to attend the vaccination point for their doses of protection once morest covid-19.
The official reiterated the advantages of receiving heterologous vaccination so, once more, he presented what are the vaccines that each citizen can receive when they go to get their booster dose.
In accordance with Resolution 2389 of 2021, people who applied the initial regimen of the Moderna and AstraZeneca biological can access the third dose of Moderna or AstraZeneca. For those who started their immunization with the single dose of Janssen, booster doses of Janssen itself, Moderna, or AstraZeneca are available. And people who applied the first two doses of Sinovac will have to reinforce their regimen with Moderna, AstraZeneca or Sinovac.
However, in recent days, the Ministry of Health notified that the Pfizer and Janssen biologicals will be applied only to people who need a second dose of the vaccination scheme, but not as a booster or third application of this cycle of immunity. The authorities recommend that anyone who requires a complementary vaccine apply the AstraZeneca vaccine, which is available at all vaccination points in the country.
Similarly, the director reiterated that “The best vaccine is the one available in our refrigerators”, explaining how reinforcements can be applied, highlighting that “at this time the secretaries must take this table into account.”
Advance by age group
As for age groups, the director also presented the progress that has been made. In the group of 70 years and over, the progress is 97.9% in first and only doses, 94.2% in second and only doses and 45.9% in reinforcements.
“Gentlemen, here in this town is where the greatest probability is that omicron will harm us. Nominally we need to look for 50% of this population for reinforcements “, Relato Bermont.
In the group of 50 to 69 years old, the advance is 88.3% in first and only ones, 81.55% in second and only ones and 29.2% in reinforcements. “That is why we must guarantee the booster dose in the population over 50 years of age,” he added.
In the range of 30 to 49 years, there is an advance of 92.1% in first and only, 74.3% in second and only and 8.2% in reinforcements. In the range of 12 to 19 years, the data indicate that there is an advance of 78.6% in first and only, 51.4% in second and only and 3.7% reinforcement. And, finally, in the group from three to 11 years old, the advance is 49.2% in the first and 21.1% in the second.
Similarly, the official highlighted that there are 66,153 people aged 70 and more susceptible to application of first doses, 1,106,752 from 50 to 59 years old, 1,102,380 from 30 to 49 years old, 3,228,289 from 12 to 29 years old and 3,618,365 minors between the ages of three and 11 who are likely to receive first doses.